Bristol-Myers Squibb (China) Investment Co., Ltd., Acetaminophen Drops, founded in 1887 in the United States, is a global diversified enterprise engaged in medical health care and personal care products based on professional scientific research
Bristol-Myers Squibb is a global biopharmaceutical company that is committed to its mission to discover, develop, and deliver innovative medicines to help patients overcome serious diseases.
Around the world, the company's medicines help millions of patients defeat diseases such as cancer, cardiovascular disease, hepatitis B, HIV/AIDS, rheumatoid arthritis and mental illness.
At Bristol-Myers Squibb, the company's biopharmaceutical strategy uniquely combines the reach and resources of a large pharmaceutical company with the entrepreneurial spirit and flexibility of a successful biotech company. With this strategy, the company focuses on the needs of its customers, with a focus on accelerating pipeline development, driving sales growth, and adhering to cost management.
The strategy works. Over the past three years, the company's total shareholder returns, including dividends, have consistently ranked among the best in the industry. The company outperformed most of the big pharma, diversification and pure-play biotechnology companies. The company has a long-term commitment to bringing value to shareholders and has paid more than 300 consecutive quarters of dividends to shareholders.
In addition, since 2002, the company has made 13 new drugs available to patients. In 2012, the company may have two newly approved drugs.
The company's R&D facility is considered to be the most productive in the industry. String of Pearls strategic innovation alliances, partnerships, and acquisitions further strengthen the company. The company's full line of pearls covers many major disease areas, including cancer, cardiovascular disease, immunology, neuroscience, and virology.
Pursuing the company's mission also means that the company is working hard to provide healthcare to patients. Companies are working to achieve this through public/private partnerships, such as Defend the Future. The company's groundbreaking $150 million program aims to help Africa defeat HIV/AIDS. In addition, through the Company's Patient Assistance Program, the Company provides free medication to patients with financial difficulties in the United States.
Innovation is key to the successful execution of a biopharma strategy. The company strengthens its innovation through a diverse workforce and an inclusive culture. Bristol-Myers Squibb is recognized year after year as one of the most popular companies for female executives and working women. Moreover, for the fourth year in a row, the Human Rights Campaign Foundation has given companies a perfect score on the Corporate Equality Index.
Protecting natural resources is also one of the company's main commitments. The company has integrated comprehensive energy management, pollution control and other measures at its facilities around the world to reduce its environmental impact. Bristol-Myers Squibb is recognized as the world's leading sustainability company.
Bristol-Myers Squibb is committed to the company's patients and customers, employees, communities around the world, shareholders, and the environment.
Finally, the company's success as a biopharmaceutical leader is measured by the extent to which the company changes the lives of patients.
Product Introduction
Acetaminophen drops, indicated for the use of fever caused by the common cold or influenza in children.
Baifuzhan is a brand of cold medicine and antipyretic analgesics produced by Squibb in Shanghai in China and the United States. At present, in China, the Baifuzha brand has one adult cold medicine product, one adult painkiller product, Jiahebaishining, and three children's antipyretic products, Children's Baishizha solution/drops/chewable tablets.
